Literature DB >> 27604723

Impact Acceleration Model of Diffuse Traumatic Brain Injury.

Sarah C Hellewell1, Jenna M Ziebell2,3, Jonathan Lifshitz2,3,4,5, M Cristina Morganti-Kossmann2,5,6.   

Abstract

The impact acceleration (I/A) model of traumatic brain injury (TBI) was developed to reliably induce diffuse traumatic axonal injury in rats in the absence of skull fractures and parenchymal focal lesions. This model replicates a pathophysiology that is commonly observed in humans with diffuse axonal injury (DAI) caused by acceleration-deceleration forces. Such injuries are typical consequences of motor vehicle accidents and falls, which do not necessarily require a direct impact to the closed skull. There are several desirable characteristics of the I/A model, including the extensive axonal injury produced in the absence of a focal contusion, the suitability for secondary insult modeling, and the adaptability for mild/moderate injury through alteration of height and/or weight. Furthermore, the trauma device is inexpensive and readily manufactured in any laboratory, and the induction of injury is rapid (~45 min per animal from weighing to post-injury recovery) allowing multiple animal experiments per day. In this chapter, we describe in detail the methodology and materials required to produce the rat model of I/A in the laboratory. We also review current adaptations to the model to alter injury severity, discuss frequent complications and technical issues encountered using this model, and provide recommendations to ensure technically sound injury induction.

Entities:  

Keywords:  Diffuse traumatic brain injury; Neuronal pathology; Rat model; Traumatic axonal injury

Mesh:

Year:  2016        PMID: 27604723     DOI: 10.1007/978-1-4939-3816-2_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice.

Authors:  Yesmine Hamood; Mauda Abdullah; Hassan El Ghoul; Nazeh Saad; Robert C Dysko; Zhi Zhang
Journal:  Brain Behav Immun Health       Date:  2022-05-13

Review 2.  Glucose transporters in brain in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-13       Impact factor: 3.657

3.  Pioglitazone Therapy and Fractures: Systematic Review and Meta- Analysis.

Authors:  Velichka Pavlova; Elena Filipova; Katya Uzunova; Krassimir Kalinov; Toni Vekov
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2018       Impact factor: 2.895

4.  Inhibition of Exosome Release Alleviates Cognitive Impairment After Repetitive Mild Traumatic Brain Injury.

Authors:  Tianpeng Hu; Zhaoli Han; Xiangyang Xiong; Meimei Li; Mengtian Guo; Zhenyu Yin; Dong Wang; Lu Cheng; Dai Li; Shishuang Zhang; Lu Wang; Jing Zhao; Qiang Liu; Fanglian Chen; Ping Lei
Journal:  Front Cell Neurosci       Date:  2022-01-27       Impact factor: 5.505

5.  The Complexity of Secondary Cascade Consequent to Traumatic Brain Injury: Pathobiology and Potential Treatments.

Authors:  Nidhi Khatri; Bommaraju Sumadhura; Sandeep Kumar; Ravinder Kumar Kaundal; Sunil Sharma; Ashok Kumar Datusalia
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

6.  Hepatocyte Growth Factor-Preconditioned Neural Progenitor Cells Attenuate Astrocyte Reactivity and Promote Neurite Outgrowth.

Authors:  James Hong; Rachel Dragas; Mohammad Khazaei; Christopher S Ahuja; Michael G Fehlings
Journal:  Front Cell Neurosci       Date:  2021-12-09       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.